Anti–IL-4Ra therapy is superior to other biologic classes in treating allergic bronchopulmonary aspergillosis by Pedro A. Lamothe, MD, PhD, Charles Lewis Humphrey Pruett, MS, Natalia Smirnova, MD, Aaron Shepherd, MD, Martin C. Runnstrom, MD, Jiwon Park, BA, Rebecca H. Zhang, MS, Leshan Zhao, MS, Colin Swenson, MD, F. Eun-Hyung Lee, MD

Get full text